Search Results 531-540 of 16161 for Fodmap
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...
Fibrosis staging is the most important factor in determining survival rates and prognosis. These stages are: F0: No scarring. F1: Mild scarring.
... . VID-20147956. Home; Brightcove-Florida PRC director explains program. 3X your impact! Give Now! Your gift can go 3X as far to shape the future of ...
About this study. This study is being done to better understand the relationship between inflammation in your AT, abnormal deposition of fat around your ...
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
The purpose of this study to explore current practices for detecting, referring, and addressing psychosocial distress in pediatric patients with C-CD through ...
The purpose of this study is to identify if there is variability across sensors at different orientation on healthy subjects. Participation eligibility.
Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...
Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.